- Home
- SDHY vs NRC Comparison
SDHY vs NRC Comparison
Compare SDHY & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDHY
- NRC
- Stock Information
- Founded
- SDHY 2020
- NRC 1981
- Country
- SDHY United States
- NRC United States
- Employees
- SDHY N/A
- NRC N/A
- Industry
- SDHY Finance/Investors Services
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SDHY Finance
- NRC Health Care
- Exchange
- SDHY Nasdaq
- NRC Nasdaq
- Market Cap
- SDHY 405.6M
- NRC 426.3M
- IPO Year
- SDHY N/A
- NRC N/A
- Fundamental
- Price
- SDHY $16.29
- NRC $17.85
- Analyst Decision
- SDHY
- NRC
- Analyst Count
- SDHY 0
- NRC 0
- Target Price
- SDHY N/A
- NRC N/A
- AVG Volume (30 Days)
- SDHY 94.0K
- NRC 97.2K
- Earning Date
- SDHY 01-01-0001
- NRC 02-11-2025
- Dividend Yield
- SDHY 8.46%
- NRC 2.79%
- EPS Growth
- SDHY N/A
- NRC N/A
- EPS
- SDHY 1.07
- NRC 1.12
- Revenue
- SDHY N/A
- NRC $144,155,000.00
- Revenue This Year
- SDHY N/A
- NRC N/A
- Revenue Next Year
- SDHY N/A
- NRC N/A
- P/E Ratio
- SDHY $14.31
- NRC $15.31
- Revenue Growth
- SDHY N/A
- NRC N/A
- 52 Week Low
- SDHY $13.93
- NRC $16.93
- 52 Week High
- SDHY $15.50
- NRC $42.18
- Technical
- Relative Strength Index (RSI)
- SDHY 31.27
- NRC 38.82
- Support Level
- SDHY $16.43
- NRC $16.93
- Resistance Level
- SDHY $16.60
- NRC $18.58
- Average True Range (ATR)
- SDHY 0.11
- NRC 0.67
- MACD
- SDHY -0.04
- NRC -0.20
- Stochastic Oscillator
- SDHY 2.96
- NRC 26.25
About SDHY PGIM Short Duration High Yield Opportunities Fund
PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return, through a combination of current income and capital appreciation. Its seeks to achieve its objective by investing in a diversified portfolio of high yield fixed income instruments.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.